No One Showed Me How: The Mentorship Gap That Leaves Researcher-Founders Navigating Alone
Academic science has one of the most sophisticated mentorship traditions in any professional domain. It stops, almost completely, at the laboratory door — and everything that lies beyond it, researchers are expected to figure out for themselves.
A polymer chemist at a Swedish university spent seven years developing a degradable adhesive with clear applications in surgical wound closure. Her supervisor was a distinguished scientist who had guided her through two grant cycles, four published papers, and a patent filing. When she decided to pursue commercialisation, she asked him for guidance. He told her, with genuine warmth and no trace of evasion, that he had no idea how any of it worked. He had never done it. He did not know anyone who had done it well. He suggested she contact the technology transfer office. She did. They handed her a one-page factsheet on spinout formation and a list of regional business support organisations. She spent the following eighteen months navigating the commercialisation process entirely alone — making decisions she did not know were consequential, missing opportunities she did not know existed, and slowly developing, through expensive trial and error, knowledge that could have been transmitted in a few months of structured guidance from someone who had been there before.
The absence of commercialisation mentorship in academic science is one of the most consistently documented and least addressed structural deficits in the university innovation system. It is invisible precisely because the mentorship that does exist — the doctoral supervisor relationship, the postdoctoral apprenticeship, the informal guidance of senior colleagues on publication and grant strategy — is so rich, so embedded, and so genuinely effective at what it covers. The gap only becomes visible at the threshold where the laboratory ends, and the commercial world begins. At that threshold, the scaffolding disappears.
The historical reasons for this gap are not difficult to trace. The mentorship tradition in academic science is built around the transmission of a specific kind of expertise: how to ask good scientific questions, how to design experiments that answer them, how to communicate findings to peers, how to build a reputation within a discipline. This tradition was formalised across the nineteenth and twentieth centuries as the research university matured, and it is genuinely one of the great achievements of academic culture — an apprenticeship model that has successfully reproduced scientific expertise across generations and disciplines for over a century.
What this tradition was never designed to transmit is commercial expertise, because for most of its history, commercial expertise was not relevant to the academic career. The professor who mentored a doctoral student in 1975 had no need to know how a licensing negotiation worked, what a convertible note was, or how to construct a market sizing analysis. These were skills for a different world — and the boundary between that world and the academic one was, by design and institutional preference, well maintained.
The commercialisation mandates of the 1980s and 1990s collapsed that boundary without rebuilding the mentorship infrastructure on the other side of it. Universities began expecting researchers to commercialise their work. They did not, in any systematic way, create the senior cohort of experienced commercialiser-researchers who could mentor the next generation through the process. Each new generation of researcher-founders had to learn the same hard lessons independently — the same mistakes with cap tables, the same misreadings of investor signals, the same misjudgements about development timelines — that their predecessors had made a decade earlier, with no institutional mechanism for the knowledge to flow between them.
A 2020 survey of academic spinout founders across twelve European countries, conducted by the European Investment Fund, found that 74% described the absence of experienced commercialisation mentorship as a significant barrier — ranking it above lack of funding, regulatory complexity, and market access difficulties. A study in the Journal of Technology Transfer found that spinout companies whose founders had access to a dedicated commercialisation mentor in the first eighteen months of operation were 2.7 times more likely to reach their first commercial revenue milestone than those without. The mentorship effect was largest not in technical domains, but in investor communication, deal structuring, and strategic prioritisation — the specific competencies that academic training systematically omits.
The consequences of the gap are not uniformly distributed. Researchers from institutions with strong entrepreneurial alumni networks — the Oxfords, the ETHs, the TU Delft communities where spinout success has produced a visible cohort of experienced founders willing to advise successors — are significantly better positioned than those at institutions where commercialisation is newer, rarer, or culturally marginal. The researcher at a regional university in Central Europe, or at a discipline-specific institute without a strong spinout tradition, does not merely have less mentorship available. They have, effectively, none.
"I made every mistake you can make in the first year of a spinout. Not because I was careless — I was meticulous. But I was meticulous about the wrong things, because I had no one to tell me what the right things were. A single conversation with someone who had done this before would have saved me six months and two hundred thousand euros."
— Founder of a diagnostics spinout, Prague, 2023The specific costs of navigating without mentorship are identifiable and recurring. In the strategic phase — the months during which a researcher is deciding whether and how to pursue commercialisation, which route to market makes sense, which investors or partners to target — the absence of experienced guidance produces decisions based on whatever information happens to be most accessible rather than most relevant. Researchers pursue spinout formation when licensing would have been faster and less capital-intensive. They target the wrong investor categories. They spend months developing business plans for markets they have not researched, in formats that no investor they are likely to meet will read.
In the investor preparation phase, the mentorship gap is most acutely felt. Preparing for a serious investment conversation is an iterative process — one that improves dramatically with feedback from someone who understands both what the investor will ask and what a credible answer looks like. Without that feedback, researchers prepare in isolation, rehearsing answers to questions they imagine investors will ask rather than questions investors actually ask — and arrive in the room with confidence that has not been stress-tested and will not hold under the specific pressure of a live due diligence conversation.
"Nobody told me that investors test your assumptions, not just your results. I was ready for every scientific question they could have asked. I was completely unprepared for the first commercial one."
The emotional cost of this isolation is significant and underreported. Commercialisation is, for most researchers, a journey undertaken against the grain of their training, their institutional culture, and often their own self-image. The PhD supervisor who provided intellectual companionship through the most demanding period of the researcher's formation is not present for this one. The peer community that offered challenge and support during the publication process has no framework for the new set of problems. The researcher proceeds alone, and the combination of technical challenge, commercial unfamiliarity, and institutional indifference produces a specific kind of exhaustion that has claimed many ventures before a single investor meeting has taken place.
What effective mentorship for researcher-founders looks like is not the same as what the university entrepreneurship ecosystem typically provides. Accelerator programmes offer cohort-based support but rarely the continuity of relationship that genuine mentorship requires. Business school advisors offer commercial expertise but frequently lack the domain knowledge to engage substantively with the science. Alumni networks offer experience but not structured transmission of it — the successful founder who agrees to a coffee meeting is not the same as the dedicated partner who is present across the arc of a commercialisation journey.
What works — and what the evidence on successful academic spinouts consistently identifies — is a relationship of sustained, personalised guidance that spans the full journey from strategic decision-making through investor preparation to the room itself. A mentor who understands the technology well enough to help frame its commercial narrative accurately. Who knows the investor landscape well enough to identify the right targets and anticipate their specific concerns. Who has been in enough funding conversations to recognise which preparation gaps will cost the researcher the meeting — and who can run the rehearsals, ask the hard questions, and deliver the honest feedback that turns a researcher's first pitch from an ordeal into a performance they can repeat.
The doctoral supervisor who shaped a scientist's intellectual formation did not do so through a workshop or a factsheet. They did it through sustained presence, honest challenge, and the accumulated transmission of hard-won expertise. The commercialisation mentor who can do the equivalent for the journey beyond the laboratory is not a luxury. For the researcher standing at that threshold alone, they are the difference between a discovery that reaches the world and one that does not.